SlideShare une entreprise Scribd logo
1  sur  27
Télécharger pour lire hors ligne
Initiation Into Injecting Drug Use In Ukraine:
Results From a Respondent Driven Sampling
Study Among Young IDUs and Non-IDU Peers
Jean-Paul Grund, Olga Balakireva, Olena Sakovich,
Yuliya Rubanets, Marina Ryabova, Cas Barendregt,
Nataliya Levchuk, Tatyana Bondar
Project Data
• Project Title: Preventing Initiation of Injecting Drug Use
amongst Vulnerable Adolescents and Youth in Ukraine
• Implemented by:
- Ukrainian Institute for Social Research
(Olga Balakireva (PI), Yuliya Rubanets, Marina
Ryabova, Nataliya Levchuk, Tatyana Bondar);
- DV8 Research, Training & Development, Rotterdam,
the Netherlands (Jean-Paul Grund (co-PI));
- Addiction Research Institute (IVO) Rotterdam, the
Netherlands (Cas Barendregt)
Acknowledgement
• Funding: UNAIDS/UNICEF (PAF)
• Project Officer: Olena Sakovich, UNICEF, Kiev
BACKGROUND:
A TWIN EPIDEMIC OF IDU AND HIV (i)
• Registered drug users in Ukraine:
– 1990
43.2 per 100K pop.
– 2005
179.2 per 100K pop. (Ministry
of Health of Ukraine. 2006)

• Number of IDUs in Ukraine:
– 560.000 (Social Monitoring Center, 2002)
– 424.700 (consensus estimate of national
HIV/AIDS specialists, 2005)
BACKGROUND:
A TWIN EPIDEMIC OF IDU AND HIV (ii)
• Injecting drug use remains main mode of HIV
transmission:
– 2005: 45.5% of PLWHA infected through IDU
(Ukrainian AIDS Center, 2006)

BUT…
– Existing HIV testing and HIV case registration
system seriously underestimates actual
number of HIV-positive IDUs (UAC /UNAIDS, 2002)
– Local Sentinel Surveillance studies suggest HIV
prevalence among IDUs between 10% and 59%,
with IDUs aged 15 to 19 at highest risk.
– IDU population keeps growing in number
STUDY OBJECTIVES
• Present prevention approaches either tend to emphasize targeted
interventions aimed at established drug injectors or public
information campaigns, aiming at informing the general public in
a ‘broadcast’ fashion.
• Importance of needle exchange, Substitution treatment and other
harm reduction interventions, but…
• Is it possible to “Break the Cycle” of initiation into IDU?
– Little scientific information is available on the determinants of initiation
into injecting drug use among youth. From Ukraine and other post Soviet
countries none whatsoever.

Study aims:
• Provide data on the process of initiation into injecting drug use
• Serve as foundation for prevention activities seeking to reduce the
incidence & prevalence of IDU
Study Design
• Literature review on (prevention of) initiation of
injecting drug use among youth and support
services for young/novice injecting drug users
(IDUs);
• In-depth interviews with young/recent IDUs;
• Quantitative survey of young/recent IDUs
and their non-injecting friends in four cities
(Kyiv, Odesa, Poltava and Pavlograd);
• Each phase informed the following
Survey Methodology
• Respondent Driven Sampling (Heckathorn,
1997, 2002) in four cities:
Kyiv, Odesa, Poltava and Pavlohrad;

• Target Populations:
1. Injecting drug users (IDUs) up to 23 years of age,
having injected at least once in the last 3 months);
not in treatment for drug addiction and not involved
in rehabilitation programs at the time of interview.
2. IDUs’ friends who do not inject drugs (non-IDUs)
up to 23 years of age (thus including non-users
(NUs) and users of non-injected drugs (NIDUs))
IDU 1 recruits 4 freinds: 3 IDUs and 1 non-IDU

IDU 1
IDU 1.1

IDU 1.2

IDU 1.3

The same scheme as for IDU-1

IDU 1.1.1

IDU 1.1.2

Non-IDU

Non-IDU respondents do not
recruit!

Non-IDU

IDU 1.1.3

The same scheme as for IDU-1

IDU 20
IDU 20.1

IDU 20.2

IDU 20.3

Non-IDU

The same scheme as for IDU-1

Seeds: IDU 1 ...... IDU20

RDS
Recruitment
Scheme
The Resulting Sample
Non-injecting friends (non-IDUs),
N=802

Kyiv

Odesa

Pavlograd

Poltava

Kyiv

Odesa

Pavlograd

Poltava

Injecting drug users
(IDUs), N=808

25%

25%

25%

25%

25%

25%

25%

25%

205

201

199

203

199

201

Use drugs
non-injectingly
(NIDUs), N=476

200

201

Do not use any
illegal drugs (NU),
N=326
Demographics

IDUs

Non-IDUs

Gender: M.
F.

78,5%
21,5%

63,3%
36,7%

Mean Age:

20 yrs.

19 yrs.

Employed:

35%

40%
Drugs of first injection by city of
residence (% )
Among all IDUs

25

60

Pavlograd

5
55

35

0

Poltava

11

77

Odesa

2
12

68

Kyiv

9
23

59
0%

10

20%

Poppy straw extract

9
40%

60%

Amphtamines

80%
Heroin

10
11
11
9
100%

Others
Social Setting of the First Hit

“Who was present at your first injection?”*
Company

%

Friends or good acquaintances

80

Person I did not know very well

20

Sexual partner

17

Stranger

7

Alone

5

* More than one answer was possible.
Social Setting of the First Hit
“Who gave you the first injection?” by gender (%)
64
Friend, acquantance

55
67
13

Self-made

4
15
8

Sexual partner

32
3
6

Drug dealer

2
7
5

Running body

4
5
1

O ther persons

3
3
0

10

20

Men

30

40

Women

50

60

All

70

80
Social Setting of the First Hit

Average age of first injection:

17.7 years

Average age of “Initiator”:

22.8 years

Initiator is usually an IDU friend
First drug of injection is usually obtained from a close
friend, free of charge
Most common location of IDU initiation:
A friend‘s apartment
Behavioral risks associated with the first
injection (i)
• “At my initiation other people
used the same drug.”
• Obtained first drug injected
as liquid in syringe
• “Each in the group had
his/her own syringe”

80%
75%
21%
Behavioral risks associated with the first
injection (ii)
• didn’t know / unsure whether syringe
was used by someone before or not

33%

– Associated with Age: Younger at initiation  increasing
incertainty;
– Associated with length of Non-IDU use:
2 Years
4 Years

32%
21%

• 50% was high on AOD
“At the time of my first injection I was under the influence of alcohol
and marijuana.” (Poltava, female, 19 years).
Behavioral risks associated with the first
injection (iii)
“Did you use a sterile needle during the first injection?"
by other drug use (%)
% 80
70
60
50
40
30
20
10
0

73
62
38

56
49

43

51

26

Had not used any stuff

Non-injecting drugs

Do not know/unsure whether the syringe was new

Alcohol

Alcohol and non-injecting
drugs

Sure, it was a new syringe
Behavioral risks associated with the first
injection (iv)
Other drug use during the first injection by gender (%)
% 60
50

55
44
38

Men

Women

40
25

30
14

20

11
5

10

6

0
Had not used any
stuff

Non-injecting drugs

Alcohol

Syringe sharing at the first injection: Men:
Women

Alcohol and noninjecting drugs

29%
51%
The reproduction of injecting drug use
• 167 IDUs (21%) initiated 605 Novice IDUs
 Reproduction Rate: 3.6 per initiator or 0.7 for
whole sample
– Males:
22%, RR 3.83
– Females: 16%, RR 2.61

“Did you ever initiate a novice?”

%

Yes, I did

21

No. of times:

7

twice

6

tree or more
No, I didn’t

once

8
79
Initiation into IDU: Planned or Spontaneous?
Planning the first and the second injection, by gender (%)
100
% 90
80
70
60
50
40
30
20
10
0

100
%

90
80
70
60
50

60

44

40
30
20
10

First injection

Men

Second
injection

45
28

0
First injection

Women

Second
injection
Did you ever want to try an injecting drug?
(%) of the NIDUs and NUs
NIDUs

NUs

No, never

56

80

Yes, a couple of times

37

17

Yes, quite often

5

1

Yes, I really would like to try an injecting
drug

2

2
Self-Assessment of the probability of
initiating IDU among NIDUs and NUs (%)
5

Sure they will try one day

10

Not going to try injecting drugs so far, but don’t know
how the things will be going later on

30
34
65

Sure they will never try injecting drugs

56
0

NIDUs

10

20

30

40

50

60

70

NUs

80

90 100
First injection:

Summary

•
•
•
•

Mostly home-produced opiate;
Taken in a group of friends;
At the apartment of a friend;
Administered by a close friend or, in the case of
women, a sexual partner;
• Obtained from a close friend, free of charge;
• Generally an unplanned event.
Additional data on:
– Motivations for & Barriers to initiation of drug
injecting
– Risk & Protective Factors
Peer-based interventions targeting (young) IDUs,

Interventions targeting IDUs to prevent initiation of
other, that is:
- to not inject in the presence of non-injectors;
- to not give other people their first injection;
- inform non-injectors on the negative effects of
injecting drug use.

• XXXXX
IDUs

Non-IDUs

aiming at changes in sub-cultural norms towards
rejecting initiation of non-IDUs:
•Do not give other people (e.g. non-IDUs friends)
their first injection
•Do not inject in the presence of non-IDUs
•Honestly inform non-IDUs on the consequences of
injecting drug use (health, habit)
•Example: Break the Cycle (Hunt 1998)

Proposed
Strategy

Peer-based interventions targeting NIDUs & experimental IDUs, aiming at

Abstinence-based drug education:
establishing sub-cultural norms favoring non-injecting modes of administration:
interventions targeting non-IDUs to prevent initiation
of injecting drug use.
•Honest information on modes of administration;
•Information on safer and effective non-IDU modes of administration
Reference:
• Jean-Paul Grund, Olga Balakireva, Olena Sakovich, Yuliya
Rubanets, Marina Ryabova, Cas Barendregt, Nataliya Levchuk,
Tatyana Bondar. Initiation into Injecting Drug Use In Ukraine:
Results From a Respondent Driven Sampling Study Among Young
IDUs and Their Non-IDU Peers. Presented at the Seventeenth
International Conference on the Reduction of Drug Related Harm,
Vancouver, Canada, May 3, 2002 (Abs.No. We.07.1).

J-P Grund

Contenu connexe

En vedette

Unit 2 summative assessment checklist
Unit 2 summative assessment checklistUnit 2 summative assessment checklist
Unit 2 summative assessment checklistmlewando30
 
Landlord-tenant Cash Lease Workshop, November 2013
Landlord-tenant Cash Lease Workshop, November 2013Landlord-tenant Cash Lease Workshop, November 2013
Landlord-tenant Cash Lease Workshop, November 2013dostdiek4
 
Contrabief garrido zenteno
Contrabief garrido zentenoContrabief garrido zenteno
Contrabief garrido zentenoPietro Castaña
 

En vedette (6)

Delhi sep in russia
Delhi sep in russiaDelhi sep in russia
Delhi sep in russia
 
Delhi roma&drugs
Delhi roma&drugsDelhi roma&drugs
Delhi roma&drugs
 
Hola
HolaHola
Hola
 
Unit 2 summative assessment checklist
Unit 2 summative assessment checklistUnit 2 summative assessment checklist
Unit 2 summative assessment checklist
 
Landlord-tenant Cash Lease Workshop, November 2013
Landlord-tenant Cash Lease Workshop, November 2013Landlord-tenant Cash Lease Workshop, November 2013
Landlord-tenant Cash Lease Workshop, November 2013
 
Contrabief garrido zenteno
Contrabief garrido zentenoContrabief garrido zenteno
Contrabief garrido zenteno
 

Similaire à Initiation into injecting drug use in ukraine

miodrag kajgana - gender roles and adherence to art
miodrag kajgana - gender roles and adherence to artmiodrag kajgana - gender roles and adherence to art
miodrag kajgana - gender roles and adherence to artPartnerships in Health
 
Final - HIV & Custodial Settings 30_Jan_2008
Final - HIV & Custodial Settings 30_Jan_2008Final - HIV & Custodial Settings 30_Jan_2008
Final - HIV & Custodial Settings 30_Jan_2008Sonia Bezziccheri
 
A bridge too near injecting drug users' sexual behaviour
A bridge too near  injecting drug users' sexual behaviourA bridge too near  injecting drug users' sexual behaviour
A bridge too near injecting drug users' sexual behaviourMd. Nakebul Kausar
 
Ippf webinar srh_hiv_pwud_27_aug2015
Ippf webinar srh_hiv_pwud_27_aug2015Ippf webinar srh_hiv_pwud_27_aug2015
Ippf webinar srh_hiv_pwud_27_aug2015Lilian Esemere Kayaro
 
160426 middletonj Preventing violence
160426 middletonj  Preventing  violence 160426 middletonj  Preventing  violence
160426 middletonj Preventing violence John Middleton
 
Epidemiological studies in psychiatry in India
Epidemiological studies in psychiatry in IndiaEpidemiological studies in psychiatry in India
Epidemiological studies in psychiatry in IndiaSujit Kumar Kar
 
Rudolph Basson: Support or punish – reconsidered approaches to drug related h...
Rudolph Basson: Support or punish – reconsidered approaches to drug related h...Rudolph Basson: Support or punish – reconsidered approaches to drug related h...
Rudolph Basson: Support or punish – reconsidered approaches to drug related h...SACAP
 
Integrating HIV Prevention into Primary Care
Integrating HIV Prevention into Primary CareIntegrating HIV Prevention into Primary Care
Integrating HIV Prevention into Primary CareCHC Connecticut
 
substance abuse imp
substance abuse imp substance abuse imp
substance abuse imp Amit Tamboli
 
Drug use patterns among participants in a woman-focused RCT in Georgia
Drug use patterns among participants in a woman-focused RCT in GeorgiaDrug use patterns among participants in a woman-focused RCT in Georgia
Drug use patterns among participants in a woman-focused RCT in GeorgiaIrma Kirtadze M.D.
 
Mr. G. Charanjit Sharma_Harm reduction for PWID and counseling needs_14-08-20...
Mr. G. Charanjit Sharma_Harm reduction for PWID and counseling needs_14-08-20...Mr. G. Charanjit Sharma_Harm reduction for PWID and counseling needs_14-08-20...
Mr. G. Charanjit Sharma_Harm reduction for PWID and counseling needs_14-08-20...AmitMohite28
 
Responding to intimate partner violence and sexual violence against women
Responding to intimate partner violence and sexual violence against womenResponding to intimate partner violence and sexual violence against women
Responding to intimate partner violence and sexual violence against womenJoao Redondo
 
Risk and stigma in seeking care and policy implications
Risk and stigma in seeking care and policy implicationsRisk and stigma in seeking care and policy implications
Risk and stigma in seeking care and policy implicationsIrma Kirtadze M.D.
 
Indonesian Harm Reduction Network - UNODC
Indonesian Harm Reduction Network - UNODCIndonesian Harm Reduction Network - UNODC
Indonesian Harm Reduction Network - UNODCGonzilla Sach
 
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonaldRx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonaldOPUNITE
 
Addressing sexual and reproductive health and rights and hiv prevention linka...
Addressing sexual and reproductive health and rights and hiv prevention linka...Addressing sexual and reproductive health and rights and hiv prevention linka...
Addressing sexual and reproductive health and rights and hiv prevention linka...gnpplus
 

Similaire à Initiation into injecting drug use in ukraine (20)

miodrag kajgana - gender roles and adherence to art
miodrag kajgana - gender roles and adherence to artmiodrag kajgana - gender roles and adherence to art
miodrag kajgana - gender roles and adherence to art
 
Final - HIV & Custodial Settings 30_Jan_2008
Final - HIV & Custodial Settings 30_Jan_2008Final - HIV & Custodial Settings 30_Jan_2008
Final - HIV & Custodial Settings 30_Jan_2008
 
A bridge too near injecting drug users' sexual behaviour
A bridge too near  injecting drug users' sexual behaviourA bridge too near  injecting drug users' sexual behaviour
A bridge too near injecting drug users' sexual behaviour
 
Hiv in ukraine
Hiv  in ukraine Hiv  in ukraine
Hiv in ukraine
 
Ippf webinar srh_hiv_pwud_27_aug2015
Ippf webinar srh_hiv_pwud_27_aug2015Ippf webinar srh_hiv_pwud_27_aug2015
Ippf webinar srh_hiv_pwud_27_aug2015
 
160426 middletonj Preventing violence
160426 middletonj  Preventing  violence 160426 middletonj  Preventing  violence
160426 middletonj Preventing violence
 
Epidemiological studies in psychiatry in India
Epidemiological studies in psychiatry in IndiaEpidemiological studies in psychiatry in India
Epidemiological studies in psychiatry in India
 
Lectura06 missingvoices
Lectura06 missingvoicesLectura06 missingvoices
Lectura06 missingvoices
 
Rudolph Basson: Support or punish – reconsidered approaches to drug related h...
Rudolph Basson: Support or punish – reconsidered approaches to drug related h...Rudolph Basson: Support or punish – reconsidered approaches to drug related h...
Rudolph Basson: Support or punish – reconsidered approaches to drug related h...
 
Integrating HIV Prevention into Primary Care
Integrating HIV Prevention into Primary CareIntegrating HIV Prevention into Primary Care
Integrating HIV Prevention into Primary Care
 
substance abuse imp
substance abuse imp substance abuse imp
substance abuse imp
 
Drug use patterns among participants in a woman-focused RCT in Georgia
Drug use patterns among participants in a woman-focused RCT in GeorgiaDrug use patterns among participants in a woman-focused RCT in Georgia
Drug use patterns among participants in a woman-focused RCT in Georgia
 
Mr. G. Charanjit Sharma_Harm reduction for PWID and counseling needs_14-08-20...
Mr. G. Charanjit Sharma_Harm reduction for PWID and counseling needs_14-08-20...Mr. G. Charanjit Sharma_Harm reduction for PWID and counseling needs_14-08-20...
Mr. G. Charanjit Sharma_Harm reduction for PWID and counseling needs_14-08-20...
 
Responding to intimate partner violence and sexual violence against women
Responding to intimate partner violence and sexual violence against womenResponding to intimate partner violence and sexual violence against women
Responding to intimate partner violence and sexual violence against women
 
Wesat2202
Wesat2202Wesat2202
Wesat2202
 
Risk and stigma in seeking care and policy implications
Risk and stigma in seeking care and policy implicationsRisk and stigma in seeking care and policy implications
Risk and stigma in seeking care and policy implications
 
NSP in Prisons:a brief overview…
NSP in Prisons:a brief overview…NSP in Prisons:a brief overview…
NSP in Prisons:a brief overview…
 
Indonesian Harm Reduction Network - UNODC
Indonesian Harm Reduction Network - UNODCIndonesian Harm Reduction Network - UNODC
Indonesian Harm Reduction Network - UNODC
 
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonaldRx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
 
Addressing sexual and reproductive health and rights and hiv prevention linka...
Addressing sexual and reproductive health and rights and hiv prevention linka...Addressing sexual and reproductive health and rights and hiv prevention linka...
Addressing sexual and reproductive health and rights and hiv prevention linka...
 

Plus de Jean-Paul Grund

Jpgrund technology & drugs, breda, 06-02-2015
Jpgrund technology & drugs, breda, 06-02-2015Jpgrund technology & drugs, breda, 06-02-2015
Jpgrund technology & drugs, breda, 06-02-2015Jean-Paul Grund
 
Grund J-P. C. (2015). redução de danos princípios e estratégias (harm reducti...
Grund J-P. C. (2015). redução de danos princípios e estratégias (harm reducti...Grund J-P. C. (2015). redução de danos princípios e estratégias (harm reducti...
Grund J-P. C. (2015). redução de danos princípios e estratégias (harm reducti...Jean-Paul Grund
 
Harm Reduction & New Psychoactive Substances. Who’s up to the Challenge?
Harm Reduction & New Psychoactive Substances.  Who’s up to the Challenge?Harm Reduction & New Psychoactive Substances.  Who’s up to the Challenge?
Harm Reduction & New Psychoactive Substances. Who’s up to the Challenge?Jean-Paul Grund
 
Serendipity & the road to theory (update 07/2014)
Serendipity & the road to theory (update 07/2014)Serendipity & the road to theory (update 07/2014)
Serendipity & the road to theory (update 07/2014)Jean-Paul Grund
 
Diffusion of Drug Trends, NPS, the Internet and Consequences for Epidemiology
Diffusion of Drug Trends, NPS, the Internet  and Consequences for EpidemiologyDiffusion of Drug Trends, NPS, the Internet  and Consequences for Epidemiology
Diffusion of Drug Trends, NPS, the Internet and Consequences for EpidemiologyJean-Paul Grund
 
Randomized Controlled Trials in Evaluating Socially Complex Interventions: A ...
Randomized Controlled Trials in Evaluating Socially Complex Interventions: A ...Randomized Controlled Trials in Evaluating Socially Complex Interventions: A ...
Randomized Controlled Trials in Evaluating Socially Complex Interventions: A ...Jean-Paul Grund
 
Dutch drug policy - coffee shops & compromise (2014)
Dutch drug policy - coffee shops & compromise (2014)Dutch drug policy - coffee shops & compromise (2014)
Dutch drug policy - coffee shops & compromise (2014)Jean-Paul Grund
 
Serendipity & the road to theory
Serendipity & the road to theorySerendipity & the road to theory
Serendipity & the road to theoryJean-Paul Grund
 
Pyramid unaids 10 19-01 (v2)
Pyramid unaids 10 19-01 (v2)Pyramid unaids 10 19-01 (v2)
Pyramid unaids 10 19-01 (v2)Jean-Paul Grund
 
Jpgrund et al peer methods review-icdrh2010-v2
Jpgrund et al peer methods review-icdrh2010-v2Jpgrund et al peer methods review-icdrh2010-v2
Jpgrund et al peer methods review-icdrh2010-v2Jean-Paul Grund
 
Jpgrund beyond hiv-sofia
Jpgrund beyond hiv-sofiaJpgrund beyond hiv-sofia
Jpgrund beyond hiv-sofiaJean-Paul Grund
 
Jpgrund bridging the streets and the institutions
Jpgrund bridging the streets and the institutionsJpgrund bridging the streets and the institutions
Jpgrund bridging the streets and the institutionsJean-Paul Grund
 
Dushanbe, 10 02 - hiv prevention & harm reduction
Dushanbe, 10 02 - hiv prevention & harm reductionDushanbe, 10 02 - hiv prevention & harm reduction
Dushanbe, 10 02 - hiv prevention & harm reductionJean-Paul Grund
 
Grund sifaneck-cross-cultural dimensions of self-regulation-towards a multi-d...
Grund sifaneck-cross-cultural dimensions of self-regulation-towards a multi-d...Grund sifaneck-cross-cultural dimensions of self-regulation-towards a multi-d...
Grund sifaneck-cross-cultural dimensions of self-regulation-towards a multi-d...Jean-Paul Grund
 
Drugs, bugs and the things that unite them
Drugs, bugs and the things that unite themDrugs, bugs and the things that unite them
Drugs, bugs and the things that unite themJean-Paul Grund
 
Jpgrund ethno toolbox 2.0!
Jpgrund   ethno toolbox 2.0!Jpgrund   ethno toolbox 2.0!
Jpgrund ethno toolbox 2.0!Jean-Paul Grund
 

Plus de Jean-Paul Grund (17)

Jpgrund technology & drugs, breda, 06-02-2015
Jpgrund technology & drugs, breda, 06-02-2015Jpgrund technology & drugs, breda, 06-02-2015
Jpgrund technology & drugs, breda, 06-02-2015
 
Grund J-P. C. (2015). redução de danos princípios e estratégias (harm reducti...
Grund J-P. C. (2015). redução de danos princípios e estratégias (harm reducti...Grund J-P. C. (2015). redução de danos princípios e estratégias (harm reducti...
Grund J-P. C. (2015). redução de danos princípios e estratégias (harm reducti...
 
Harm Reduction & New Psychoactive Substances. Who’s up to the Challenge?
Harm Reduction & New Psychoactive Substances.  Who’s up to the Challenge?Harm Reduction & New Psychoactive Substances.  Who’s up to the Challenge?
Harm Reduction & New Psychoactive Substances. Who’s up to the Challenge?
 
Serendipity & the road to theory (update 07/2014)
Serendipity & the road to theory (update 07/2014)Serendipity & the road to theory (update 07/2014)
Serendipity & the road to theory (update 07/2014)
 
Diffusion of Drug Trends, NPS, the Internet and Consequences for Epidemiology
Diffusion of Drug Trends, NPS, the Internet  and Consequences for EpidemiologyDiffusion of Drug Trends, NPS, the Internet  and Consequences for Epidemiology
Diffusion of Drug Trends, NPS, the Internet and Consequences for Epidemiology
 
Randomized Controlled Trials in Evaluating Socially Complex Interventions: A ...
Randomized Controlled Trials in Evaluating Socially Complex Interventions: A ...Randomized Controlled Trials in Evaluating Socially Complex Interventions: A ...
Randomized Controlled Trials in Evaluating Socially Complex Interventions: A ...
 
Dutch drug policy - coffee shops & compromise (2014)
Dutch drug policy - coffee shops & compromise (2014)Dutch drug policy - coffee shops & compromise (2014)
Dutch drug policy - coffee shops & compromise (2014)
 
Serendipity & the road to theory
Serendipity & the road to theorySerendipity & the road to theory
Serendipity & the road to theory
 
Pyramid unaids 10 19-01 (v2)
Pyramid unaids 10 19-01 (v2)Pyramid unaids 10 19-01 (v2)
Pyramid unaids 10 19-01 (v2)
 
Jpgrund et al peer methods review-icdrh2010-v2
Jpgrund et al peer methods review-icdrh2010-v2Jpgrund et al peer methods review-icdrh2010-v2
Jpgrund et al peer methods review-icdrh2010-v2
 
Jpgrund beyond hiv-sofia
Jpgrund beyond hiv-sofiaJpgrund beyond hiv-sofia
Jpgrund beyond hiv-sofia
 
Safer injecting
Safer injectingSafer injecting
Safer injecting
 
Jpgrund bridging the streets and the institutions
Jpgrund bridging the streets and the institutionsJpgrund bridging the streets and the institutions
Jpgrund bridging the streets and the institutions
 
Dushanbe, 10 02 - hiv prevention & harm reduction
Dushanbe, 10 02 - hiv prevention & harm reductionDushanbe, 10 02 - hiv prevention & harm reduction
Dushanbe, 10 02 - hiv prevention & harm reduction
 
Grund sifaneck-cross-cultural dimensions of self-regulation-towards a multi-d...
Grund sifaneck-cross-cultural dimensions of self-regulation-towards a multi-d...Grund sifaneck-cross-cultural dimensions of self-regulation-towards a multi-d...
Grund sifaneck-cross-cultural dimensions of self-regulation-towards a multi-d...
 
Drugs, bugs and the things that unite them
Drugs, bugs and the things that unite themDrugs, bugs and the things that unite them
Drugs, bugs and the things that unite them
 
Jpgrund ethno toolbox 2.0!
Jpgrund   ethno toolbox 2.0!Jpgrund   ethno toolbox 2.0!
Jpgrund ethno toolbox 2.0!
 

Dernier

Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..AneriPatwari
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfDivya Kanojiya
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medicationMohamadAlhes
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMADivya Kanojiya
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxL1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxDr Bilal Natiq
 

Dernier (20)

Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdf
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medication
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxL1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
 

Initiation into injecting drug use in ukraine

  • 1. Initiation Into Injecting Drug Use In Ukraine: Results From a Respondent Driven Sampling Study Among Young IDUs and Non-IDU Peers Jean-Paul Grund, Olga Balakireva, Olena Sakovich, Yuliya Rubanets, Marina Ryabova, Cas Barendregt, Nataliya Levchuk, Tatyana Bondar
  • 2. Project Data • Project Title: Preventing Initiation of Injecting Drug Use amongst Vulnerable Adolescents and Youth in Ukraine • Implemented by: - Ukrainian Institute for Social Research (Olga Balakireva (PI), Yuliya Rubanets, Marina Ryabova, Nataliya Levchuk, Tatyana Bondar); - DV8 Research, Training & Development, Rotterdam, the Netherlands (Jean-Paul Grund (co-PI)); - Addiction Research Institute (IVO) Rotterdam, the Netherlands (Cas Barendregt)
  • 3. Acknowledgement • Funding: UNAIDS/UNICEF (PAF) • Project Officer: Olena Sakovich, UNICEF, Kiev
  • 4. BACKGROUND: A TWIN EPIDEMIC OF IDU AND HIV (i) • Registered drug users in Ukraine: – 1990 43.2 per 100K pop. – 2005 179.2 per 100K pop. (Ministry of Health of Ukraine. 2006) • Number of IDUs in Ukraine: – 560.000 (Social Monitoring Center, 2002) – 424.700 (consensus estimate of national HIV/AIDS specialists, 2005)
  • 5. BACKGROUND: A TWIN EPIDEMIC OF IDU AND HIV (ii) • Injecting drug use remains main mode of HIV transmission: – 2005: 45.5% of PLWHA infected through IDU (Ukrainian AIDS Center, 2006) BUT… – Existing HIV testing and HIV case registration system seriously underestimates actual number of HIV-positive IDUs (UAC /UNAIDS, 2002) – Local Sentinel Surveillance studies suggest HIV prevalence among IDUs between 10% and 59%, with IDUs aged 15 to 19 at highest risk. – IDU population keeps growing in number
  • 6. STUDY OBJECTIVES • Present prevention approaches either tend to emphasize targeted interventions aimed at established drug injectors or public information campaigns, aiming at informing the general public in a ‘broadcast’ fashion. • Importance of needle exchange, Substitution treatment and other harm reduction interventions, but… • Is it possible to “Break the Cycle” of initiation into IDU? – Little scientific information is available on the determinants of initiation into injecting drug use among youth. From Ukraine and other post Soviet countries none whatsoever. Study aims: • Provide data on the process of initiation into injecting drug use • Serve as foundation for prevention activities seeking to reduce the incidence & prevalence of IDU
  • 7. Study Design • Literature review on (prevention of) initiation of injecting drug use among youth and support services for young/novice injecting drug users (IDUs); • In-depth interviews with young/recent IDUs; • Quantitative survey of young/recent IDUs and their non-injecting friends in four cities (Kyiv, Odesa, Poltava and Pavlograd); • Each phase informed the following
  • 8. Survey Methodology • Respondent Driven Sampling (Heckathorn, 1997, 2002) in four cities: Kyiv, Odesa, Poltava and Pavlohrad; • Target Populations: 1. Injecting drug users (IDUs) up to 23 years of age, having injected at least once in the last 3 months); not in treatment for drug addiction and not involved in rehabilitation programs at the time of interview. 2. IDUs’ friends who do not inject drugs (non-IDUs) up to 23 years of age (thus including non-users (NUs) and users of non-injected drugs (NIDUs))
  • 9. IDU 1 recruits 4 freinds: 3 IDUs and 1 non-IDU IDU 1 IDU 1.1 IDU 1.2 IDU 1.3 The same scheme as for IDU-1 IDU 1.1.1 IDU 1.1.2 Non-IDU Non-IDU respondents do not recruit! Non-IDU IDU 1.1.3 The same scheme as for IDU-1 IDU 20 IDU 20.1 IDU 20.2 IDU 20.3 Non-IDU The same scheme as for IDU-1 Seeds: IDU 1 ...... IDU20 RDS Recruitment Scheme
  • 10. The Resulting Sample Non-injecting friends (non-IDUs), N=802 Kyiv Odesa Pavlograd Poltava Kyiv Odesa Pavlograd Poltava Injecting drug users (IDUs), N=808 25% 25% 25% 25% 25% 25% 25% 25% 205 201 199 203 199 201 Use drugs non-injectingly (NIDUs), N=476 200 201 Do not use any illegal drugs (NU), N=326
  • 12.
  • 13. Drugs of first injection by city of residence (% ) Among all IDUs 25 60 Pavlograd 5 55 35 0 Poltava 11 77 Odesa 2 12 68 Kyiv 9 23 59 0% 10 20% Poppy straw extract 9 40% 60% Amphtamines 80% Heroin 10 11 11 9 100% Others
  • 14. Social Setting of the First Hit “Who was present at your first injection?”* Company % Friends or good acquaintances 80 Person I did not know very well 20 Sexual partner 17 Stranger 7 Alone 5 * More than one answer was possible.
  • 15. Social Setting of the First Hit “Who gave you the first injection?” by gender (%) 64 Friend, acquantance 55 67 13 Self-made 4 15 8 Sexual partner 32 3 6 Drug dealer 2 7 5 Running body 4 5 1 O ther persons 3 3 0 10 20 Men 30 40 Women 50 60 All 70 80
  • 16. Social Setting of the First Hit Average age of first injection: 17.7 years Average age of “Initiator”: 22.8 years Initiator is usually an IDU friend First drug of injection is usually obtained from a close friend, free of charge Most common location of IDU initiation: A friend‘s apartment
  • 17. Behavioral risks associated with the first injection (i) • “At my initiation other people used the same drug.” • Obtained first drug injected as liquid in syringe • “Each in the group had his/her own syringe” 80% 75% 21%
  • 18. Behavioral risks associated with the first injection (ii) • didn’t know / unsure whether syringe was used by someone before or not 33% – Associated with Age: Younger at initiation  increasing incertainty; – Associated with length of Non-IDU use: 2 Years 4 Years 32% 21% • 50% was high on AOD “At the time of my first injection I was under the influence of alcohol and marijuana.” (Poltava, female, 19 years).
  • 19. Behavioral risks associated with the first injection (iii) “Did you use a sterile needle during the first injection?" by other drug use (%) % 80 70 60 50 40 30 20 10 0 73 62 38 56 49 43 51 26 Had not used any stuff Non-injecting drugs Do not know/unsure whether the syringe was new Alcohol Alcohol and non-injecting drugs Sure, it was a new syringe
  • 20. Behavioral risks associated with the first injection (iv) Other drug use during the first injection by gender (%) % 60 50 55 44 38 Men Women 40 25 30 14 20 11 5 10 6 0 Had not used any stuff Non-injecting drugs Alcohol Syringe sharing at the first injection: Men: Women Alcohol and noninjecting drugs 29% 51%
  • 21. The reproduction of injecting drug use • 167 IDUs (21%) initiated 605 Novice IDUs  Reproduction Rate: 3.6 per initiator or 0.7 for whole sample – Males: 22%, RR 3.83 – Females: 16%, RR 2.61 “Did you ever initiate a novice?” % Yes, I did 21 No. of times: 7 twice 6 tree or more No, I didn’t once 8 79
  • 22. Initiation into IDU: Planned or Spontaneous? Planning the first and the second injection, by gender (%) 100 % 90 80 70 60 50 40 30 20 10 0 100 % 90 80 70 60 50 60 44 40 30 20 10 First injection Men Second injection 45 28 0 First injection Women Second injection
  • 23. Did you ever want to try an injecting drug? (%) of the NIDUs and NUs NIDUs NUs No, never 56 80 Yes, a couple of times 37 17 Yes, quite often 5 1 Yes, I really would like to try an injecting drug 2 2
  • 24. Self-Assessment of the probability of initiating IDU among NIDUs and NUs (%) 5 Sure they will try one day 10 Not going to try injecting drugs so far, but don’t know how the things will be going later on 30 34 65 Sure they will never try injecting drugs 56 0 NIDUs 10 20 30 40 50 60 70 NUs 80 90 100
  • 25. First injection: Summary • • • • Mostly home-produced opiate; Taken in a group of friends; At the apartment of a friend; Administered by a close friend or, in the case of women, a sexual partner; • Obtained from a close friend, free of charge; • Generally an unplanned event. Additional data on: – Motivations for & Barriers to initiation of drug injecting – Risk & Protective Factors
  • 26. Peer-based interventions targeting (young) IDUs, Interventions targeting IDUs to prevent initiation of other, that is: - to not inject in the presence of non-injectors; - to not give other people their first injection; - inform non-injectors on the negative effects of injecting drug use. • XXXXX IDUs Non-IDUs aiming at changes in sub-cultural norms towards rejecting initiation of non-IDUs: •Do not give other people (e.g. non-IDUs friends) their first injection •Do not inject in the presence of non-IDUs •Honestly inform non-IDUs on the consequences of injecting drug use (health, habit) •Example: Break the Cycle (Hunt 1998) Proposed Strategy Peer-based interventions targeting NIDUs & experimental IDUs, aiming at Abstinence-based drug education: establishing sub-cultural norms favoring non-injecting modes of administration: interventions targeting non-IDUs to prevent initiation of injecting drug use. •Honest information on modes of administration; •Information on safer and effective non-IDU modes of administration
  • 27. Reference: • Jean-Paul Grund, Olga Balakireva, Olena Sakovich, Yuliya Rubanets, Marina Ryabova, Cas Barendregt, Nataliya Levchuk, Tatyana Bondar. Initiation into Injecting Drug Use In Ukraine: Results From a Respondent Driven Sampling Study Among Young IDUs and Their Non-IDU Peers. Presented at the Seventeenth International Conference on the Reduction of Drug Related Harm, Vancouver, Canada, May 3, 2002 (Abs.No. We.07.1). J-P Grund